|
Chalkias A, Huang Y, Ismail A, Pantazopoulos I, Papagiannakis N, Bitterman B, Anderson E, Catalan T, Erne GK, Tilley CR, Alaka A, Amadi KM, Presswalla F, Blakely P, Bernal-Morell E, Cebreiros Lopez I, Eugen-Olsen J, Garcia de Guadiana Romualdo L, Giamarellos-Bourboulis EJ, Loosen SH, Reiser J, Tacke F, Skoulakis A, Laou E, Banerjee M, Pop-Busui R, Hayek SS; International Study of Inflammation in COVID-19 (ISIC) Investigator Group. Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study. Crit Care Med. 2024 Jun 1;52(6):930-941. doi: 10.1097/CCM.0000000000006229. Epub 2024 Feb 23. PubMed PMID: 38391282.
AÑO: 2024; IF: 6.0
|
|
Ramírez-Olivencia G., Arribas M.V., García M.M.V., Casabona J., Martínez M.J., De Novales F.J.M., García E.O., Ubeda A.C., Muñoz P., Veintimilla C., López P.Á., De La Serna J.I.B., Mora M., Camacho I.P., López-Contreras González J., Liarte G., Ryan P., Guerra G.J., Gallego M.J.V., Gutiérrez M.J.U., Betancor M.A.H., Beamonte A.M.M., González E.L., Serrano A.M., Jiménez J.A.L., Sancho A.R., Flórez J.A., De Cea M., Lorite M.N.N., Corma-Gómez A., Ocete M.D., Sacristán M.S., Segarra O.M., Román A.R., Sánchez E.D., Tendero D.T., Borrego B.V., Gámez S.L.S., Den Eynde E.V., González A.P., Serra F.A., González-Ruano Pérez P., Neira D.V.G., Amador-Prous C., Galparsoro H.A., Martín L.M., Rosado D.G., Expósito M., Fernández-Llamazares G.S., Soto M.B., Rodríguez M.Á.M., Castellano M.M.T., Masiá M.M., Navarro A.M.C., Berrocal M.A.S., Gómez L.S., Alonso A.V., Artero E.Á., Barber M.D.C.S., Morell E.B., Ayerdi , Acosta I.C., Baza B. Clinical and Epidemiological Characteristics of the 2022 Mpox Outbreak in Spain (CEME-22 Study). Open Forum Infectious Diseases. 1 March 2024. 11. 10.1093/ofid/ofae105
AÑO: 2024; IF: 3.8
|
|
Serrano Diaz L, Iniesta Navalon C, Gomez Espin R, Nicolas De Prado I, Bernal Morell E, Rentero Redondo L. Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study. Gastroenterol Hepatol. 2024 Jun-Jul;47(6):553-561. doi: 10.1016/j.gastrohep.2023.08.004. Epub 2023 Aug 18. English, Spanish. PubMed PMID: 37597745.
AÑO: 2024; IF: 1.9
|
|
Wang R, Underwood M, Llibre JM, Bernal Morell E, Brinson C, Sanz Moreno J, Scholten S, Moore R, Saggu P, Oyee J, Moodley R, Wynne B, Kisare M, Jones B, Ait-Khaled M. Very-Low-Level Viremia, Inflammatory Biomarkers, and Associated Baseline Variables: Three-Year Results of the Randomized TANGO Study. Open Forum Infect Dis. 2023 Dec 9;11(1):ofad626. doi: 10.1093/ofid/ofad626. eCollection 2024 Jan. PubMed PMID: 38213637; PubMed Central PMCID: PMC10783236.
AÑO: 2024; IF: 3.8
|
|
Elen S, Bjorkman P, Zazzi M, Bohm M, Bernal E, Sonnerborg A, Elvstam O; EuResist Network Study Group. Low-level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression. HIV Med. 2024 Jan;25(1):107-116. doi: 10.1111/hiv.13541. Epub 2023 Sep 18. PubMed PMID: 37721192.
AÑO: 2024; IF: 2.8
|